Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04408222 · ClinicalTrials.gov registry record
Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
A clinical trial of Corona Virus Infection and Oxygen Deficiency, sponsored by Columbia University.
- Completed
- Registry status
- 29
- Enrollment target
- 1
- Study location
NCT04408222: Completed study of Corona Virus Infection and Oxygen Deficiency, sponsored by Columbia University.
NCT04408222 is a study of Corona Virus Infection and Oxygen Deficiency that has completed, run by Columbia University. The registered enrollment target is 29 participants, below the 585-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04408222, a study of Corona Virus Infection and Oxygen Deficiency, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to retrospectively review clinical data to determine whether awake proning improves oxygenation in spontaneously breathing patients with COVID-19 severe hypoxemic respiratory failure.
Primary Outcome
SpO2 was measured by peripheral pulse oximetry.
Conditions Studied
Interventions
- OTHER Awake proning
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2022-03-06 |
What the finished NCT04408222 record still lists
NCT04408222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 585-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Corona Virus Infection appearing as the primary indexed condition, and to 1 intervention - of which Awake proning is the first listed.
NCT04408222 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04408222 about?
NCT04408222 is a clinical study titled "Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure". The purpose of this study is to retrospectively review clinical data to determine whether awake proning improves oxygenation in spontaneously breathing patients with COVID-19 severe hypoxemic respiratory failure.
What is the current status of trial NCT04408222?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2020-04-16. Estimated completion is 2022-03-06.
What conditions does trial NCT04408222 study?
This clinical trial studies the following conditions: Corona Virus Infection, Oxygen Deficiency.
What interventions are being tested in trial NCT04408222?
The interventions under investigation include: Awake proning (OTHER).
Who is sponsoring clinical trial NCT04408222?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04408222 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corona Virus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04408222's enrollment target sits among peer trials
29 25th of 28 higher than 3 of 28 other Corona Virus Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Corona Virus Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
RECRUITING
-
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
RECRUITING
-
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
RECRUITING
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
KIDney Injury in Times of COVID-19 (KIDCOV)
RECRUITING
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI